*Sir*---We read with great interest the statement from Nair and colleagues of the British Society of Thoracic Imaging (BSTI), which provides a thorough insight into the role of imaging in combating the COVID-19 pandemic; however, we noticed a potentially consequential error within the text. In answering Question 2, the authors comment that "CXR may be abnormal in the majority of COVID-19 cases", incorrectly inferring that the study of Huang *et al.* found "bilateral radiographic abnormalities in 40/41 (98%) of cases".[@bib1] The study of Huang *et al.* in *The Lancet* does mistakenly state that they found "bilateral involvement of chest radiographs" in 40/41 patients in Table 2 of their results; however, from reading the main text, it is clear that the imaging method they are referring to is actually chest computed tomography (CT), not chest radiography (CXR): "On admission, abnormalities in chest CT images were detected among all patients. Of the 41 patients, 40 (98%) had bilateral involvement (Table 2)".[@bib2] The mismatch between the results table and the main text in *The Lancet* may have contributed to this error.

In fact, it is evident from current literature that the sensitivity of CXR is limited for COVID-19. The study of Guan *et al.*, also cited by Nair *et al.,* reported CXR abnormalities in only 162/274 (59.1%) of COVID-19 patients.[@bib3] In addition, a more recent study by Wong *et al.* reported abnormal CXR in 44/64 (68.8%) of COVID-19 patients on presentation[@bib4]; however, it is important to note that both of these studies included hospitalised patients, representing individuals with more severe illness.

A recently published study from New York City presents a different picture of the sensitivity of CXR in ambulatory care. Weinstock *et al.* reported CXR findings of 636 COVID-19 patients presenting to urgent-care centres and found that only 168 (26.4%) were reported originally as abnormal.[@bib5] Subsequently, they had 11 board-certified radiologists re-read these radiographs with prior knowledge of the patients\' COVID-19 diagnosis. In spite of this, the panel classified only 41.7% of CXR findings as abnormal.[@bib5]

Therefore, in light of the above, it is possible that CXR may not be abnormal in the majority of COVID-19 cases presenting to emergency departments.
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